Hospital Pharmacist's Letter | Trusted CE & Recommendations

Current Issue

July 2025 Issue

Expect a Limited Role for Ceftobiprole

You’ll get questions about ceftobiprole medocaril (Zevtera)...

Resources

Other: Ceftobiprole (Zevtera)
Chart: Skin and Soft Tissue Infections
Chart: Managing Community-Acquired Pneumonia and Aspiration Pneumonia in Adults
FAQ: Resistant Gram-Negative Bacterial Infections

Don’t Let the Pneumatic Tube System Shake You Up

You can help make sure all meds with certain characteristics are included when you update your “do not tube” list...

Drive Home the Importance of Home Med Best Practices

You can help decrease errors when patients bring their home meds into the hospital...

Manage Meds in Patients With Alpha-Gal Syndrome

You’ll hear buzz about alpha-gal syndrome (AGS)...

GO TO FULL ISSUE

CE & Training

INTERACTIVE SELF STUDY CE: Cannabinoids: Efficacy and Safety

CE-IN-THE-LETTER: Hospital Pharmacist's Letter July 2025

LIVE CE: Pharmacy Essential Updates July 2025

PODCAST CE: Medication Talk - Antidepressant Insights

GO TO CE & TRAINING ORGANIZER >

Featured Clinical Resources

Group Purchases & Pricing

Hospital Pharmacist’s Letter is eligible for bulk discounts. Easily manage pharmacy-specific competency and compliance training. Bundle with other products for significant savings. Request information